SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-127644
Filing Date
2022-04-28
Accepted
2022-04-28 16:20:31
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d356025ddefa14a.htm DEFA14A 9163
2 GRAPHIC g356025g34b68.jpg GRAPHIC 193602
3 GRAPHIC g356025g89d34.jpg GRAPHIC 336732
  Complete submission text file 0001193125-22-127644.txt   740829
Mailing Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060
Business Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060 540-818-2844
Landos Biopharma, Inc. (Filer) CIK: 0001785345 (see all company filings)

IRS No.: 815085535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39971 | Film No.: 22866921
SIC: 2834 Pharmaceutical Preparations